KCM
FATE icon

Kennedy Capital Management’s Fate Therapeutics FATE Stock Holding History

Kennedy Capital Management’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-104,881
Closed -$2.35M – 622
2022
Q3 		$2.35M Sell
104,881
-725
-0.7% -$20.9K 0.07% 391
2022
Q2 		$2.62M Sell
105,606
-1,194
-1% -$32.9K 0.07% 386
2022
Q1 		$4.14M Buy
106,800
+848
+0.8% +$32.8K 0.1% 347
2021
Q4 		$6.2M Sell
105,952
-21,158
-17% -$1.2M 0.13% 295
2021
Q3 		$7.53M Buy
127,110
+16,584
+15% +$1.3M 0.17% 224
2021
Q2 		$9.59M Buy
+110,526
New +$8.91M 0.21% 172
2020
Q2 		– Sell
-75,200
Closed -$1.67M – 679
2020
Q1 		$1.67M Buy
+75,200
New +$1.9M 0.06% 493

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return